News & Events

News & Events2022-01-20T15:51:55+00:00

NEWS

See the latest PIR International News, Articles and Network Updates.

Gill Dines – BioLeader Interview

22 November 2023|

Chief Scientific Offer, Juvenescence (November 2023) Gillian (Gill) Dines is a highly accomplished pharmaceutical executive with 30+ years of experience in research, development, approval, and commercialization of new medicines in both “Big Pharma” and as an entrepreneur in the Biotech [...]

Richard Bungay – BioLeader Interview

08 November 2023|

Chief Executive Offer, Imophoron (November 2023) Richard was appointed as Chief Executive Officer of Imophoron in November 2022. Formerly, he was Chief Executive Officer of AIM-listed Diurnal Group plc, where he led the sale of the company to Neurocrine Biosciences [...]

Sven Kili – BioLeader Interview

25 October 2023|

Cell & Gene Therapy Specialist and Board Member (October 2023) Dr Sven Kili, is Principal at Sven Kili Consulting Ltd. where he provides specialist strategic consulting services to innovative Cell & Gene Therapy companies. His clients include small and [...]

2023 EU/UK Biotech Board Remuneration & Diversity Study

12 October 2023|

PIR International’s 2023 EU/UK Biotech Board Remuneration & Diversity Study is a data-driven resource that empowers executives, investors and the boardroom with the insights they need to improve board governance, top-level business decisions and truly excel. This strictly independent, [...]

Go to Top